Semax

Semax is a synthetic peptide analogue derived from the adrenocorticotropic hormone fragment ACTH (4–7), structurally modified with a Pro-Gly-Pro extension to enhance biological stability and support blood-brain barrier penetration within research settings. Originally developed for neurological and neuroregulatory investigations, Semax has been widely studied in laboratory models involving cognitive signaling, neuroprotection, stress-response modulation, and neurotransmitter regulation. Research suggests Semax may influence several neurochemical pathways associated with dopamine, serotonin, and brain-derived neurotrophic factor (BDNF) expression. Experimental studies have investigated its potential role in supporting neuronal signaling, neuroplasticity, memory formation, attention mechanisms, and stress adaptation. Additional investigations have explored its interaction with peptide-degrading enzymes and the modulation of enkephalin activity within central nervous system models. Within laboratory environments, Semax has also been studied in models involving ischemic response, vascular regulation, neural recovery processes, and adaptive cognitive performance under stress conditions. Its enhanced structural stability and extended resistance to enzymatic degradation have made it a prominent compound in modern neuropeptide research. Manufactured to strict research-grade standards, each batch undergoes independent analytical verification through ISO-accredited laboratories for purity, identity, sterility, and consistency.